David T. Valenta

Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector

Harry E. Gruber, Joan M. Robbins, J. Hlavaty, 2011, Neuro-oncology.

Polymer particle shape independently influences binding and internalization by macrophages.

Samir Mitragotri, Gaurav Sharma, Jeffrey W. Smith, 2010, Journal of controlled release : official journal of the Controlled Release Society.

What Is So Special About Apolipoprotein AI in Reverse Cholesterol Transport?

K. Rye, L. Curtiss, David T. Valenta, 2006, Arteriosclerosis, thrombosis, and vascular biology.

Overexpression of human ApoAI transgene provides long-term atheroprotection in LDL receptor-deficient mice.

L. Curtiss, David T. Valenta, Joshua J Bulgrien, 2006, Atherosclerosis.

Lipoprotein-Associated Phospholipase A2 and Cardiovascular Risk: State of the Evidence and Future Directions

L. Curtiss, David T. Valenta, 2005 .

Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization

M. Landers, S. Werner, D. Marrinucci, 2015, Journal of circulating biomarkers.

TARGETING OF MACROPHAGE FOAM CELLS IN ATHEROSCLEROTIC PLAQUE USING OLIGONUCLEOTIDE-FUNCTIONALIZED NANOPARTICLES.

Jeffrey W. Smith, G. Sharma, W. Stallcup, 2010, Nano LIFE.

Atheroprotective Potential of Macrophage-Derived Phospholipid Transfer Protein in Low-Density Lipoprotein Receptor–Deficient Mice Is Overcome by Apolipoprotein AI Overexpression

L. Lagrost, L. Curtiss, David T. Valenta, 2006, Arteriosclerosis, thrombosis, and vascular biology.

Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiency Published, JLR Papers in Press, October 10, 2007.

L. Curtiss, David T. Valenta, Joshua J Bulgrien, 2008, Journal of Lipid Research.